October « 2013 « Science and Enterprise

Government Shut-Down Another Body Blow Say Life Scientists

By Alan, on October 8th, 2013%

UC-San Diego’s Don Cleveland, ASCB president, called basic research “a spectacular investment.” (A. Kotok)

The government shut-down, said a group of researchers, is taking a large and lasting toll on life sciences in the U.S., with the ripples being felt in the economy at large. The life scientists spoke today at a press . . . → Read More: Government Shut-Down Another Body Blow Say Life Scientists

Research Aims to Standardize, Improve Medication Labels

By Alan, on October 8th, 2013%

(Photos8.com)

A study by Northwestern University’s medical school in Chicago will test new methods for physicians to write prescriptions and pharmacists to interpret those instructions for labels on drug containers. The pharmaceutical company Merck is funding the project, with participation from the drug store chain Walgreens and Alliance of Chicago community health centers.

Mid-Air Tactile Sensory Ultrasound Technology Developed

By Alan, on October 7th, 2013%

(University of Bristol)

Computer scientists at University of Bristol in the U.K. developed a system for conveying information through a sense of touch in mid-air without physically touching a screen or device. The team from Bristol’s Interaction and Graphics lab, led by doctoral student Tom Carter will present its findings and demonstrate the technology . . . → Read More: Mid-Air Tactile Sensory Ultrasound Technology Developed

Biotech Company to Go Public in $86 Million IPO

By Alan, on October 7th, 2013%

Sickle-shaped and normal blood cells (Medline/NIH)

GlycoMimetics Inc., a biotechnology company in Gaithersburg, Maryland, filed its registration with the U.S. Securities and Exchange Commission for a proposed initial public offering (IPO) of common stock. Fortune Magazine’s Term Sheet page reports the company aims to raise $86.25 million through the IPO, and trade on the . . . → Read More: Biotech Company to Go Public in $86 Million IPO

P&G Seeking Ideas, Partners in Inkjet Printing Challenge

By Alan, on October 4th, 2013%

Procter & Gamble Company in Cincinnati is seeking new ideas for applications of 3-D inkjet printing to add consumer appeal to packaging, as well as collaborators to bring those ideas to fruition. The campaign to find these ideas and partners is contained in a new challenge on InnoCentive, which has a deadline of 30 October . . . → Read More: P&G Seeking Ideas, Partners in Inkjet Printing Challenge

Dow AgroSciences Developing Insect-Resistant Soybean Traits

By Alan, on October 4th, 2013%

Soybean field (Agricultural Research Service/USDA)

Dow AgroSciences in Indianapolis, a subsidiary of Dow Chemical Company, is developing genetically engineered traits that provide soybeans with a greater ability to resist attacks from insects that chew on their plants. The company in a statement says it plans to submit its soybean traits for regulatory approval . . . → Read More: Dow AgroSciences Developing Insect-Resistant Soybean Traits

3-D Printing Lifecycle Shown More Environmentally Friendly

By Alan, on October 3rd, 2013%

Joshua Pearce holding 3-D printed item, and 3-D printer in background (Michigan Technological University)

Materials scientists at Michigan Technological University in Houghton found that in a lifecycle analysis of production processes, distributed three-dimensional printing can have a smaller environmental impact than conventional manufacturing. Michigan Tech’s Joshua Pearce and graduate student Megan Kreiger published . . . → Read More: 3-D Printing Lifecycle Shown More Environmentally Friendly

Early Clinical Trial Shows RNA Therapy Lowers Cholesterol

By Alan, on October 3rd, 2013%

(Yale School of Medicine/Wikimedia Commons)

A clinical trial by the biopharmaceutical company Alnylam Pharmaceuticals in Cambridge, Massachusetts shows that one dose of a drug made from interfering ribonucleic acid (RNA) cuts LDL, or bad, cholesterol levels more than a placebo. Results of the study, conducted with colleagues from University of Texas-Southwestern in Dallas . . . → Read More: Early Clinical Trial Shows RNA Therapy Lowers Cholesterol

Pfizer Licenses University Institute’s Obesity Research

By Alan, on October 2nd, 2013%

Michel Bouvier (Université de Montréal)

The global pharmaceutical company Pfizer is funding research at Université de Montréal in Quebec, Canada to identify cellular pathways in genetic defects leading to therapies for early-onset morbid obesity. Financial aspects of the collaboration, which gives Pfizer a license to commercially develop results of the research, were not . . . → Read More: Pfizer Licenses University Institute’s Obesity Research

Chain Restaurants Still Serving High Calorie, Sodium Meals

By Alan, on October 2nd, 2013%

(Genome.gov)

Public health researchers at University of California in Davis and Rand Corporation in Santa Monica found restaurant chains in the U.S. continue to serve meals high in calories and sodium, despite requirements to post nutritional data about their menus. UC-Davis’s Helen Wu and Rand economist Roland Sturm published their findings yesterday online . . . → Read More: Chain Restaurants Still Serving High Calorie, Sodium Meals

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise